Home » Posts tagged with » Richard Saynor
Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal

Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal

Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics business in a deal worth up to $500 million. The deal gives Sandoz global rights to the Zinnat, Zinacef, and Fortum brands in over 100 markets. However, the deal does not include the rights in the US, Australia, and Germany […]

Novartis’ Sandoz to acquire Aspen’s Japanese pharma business

Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen Pharmacare in a deal valued up to €400 million, as per the latest pharma acquisition news. The acquisition includes shares in Aspen Japan and associated assets held by the South […]

Continue reading …